课题基金 / 基金详情

DURATION OF HUMAN PAPILLOMA VIRUS (HPV) TYPE-SPECIFIC ANTIBODY

DURATION OF HUMAN PAPILLOMA VIRUS (HPV) TYPE-SPECIFIC ANTIBODY
人乳头瘤病毒 (HPV) 类型特异性抗体的持续时间
批准号:
8356754
负责人:
William Thomas Shearer
金额:
$0.26万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-12-01 至 2011-11-30

项目摘要

项目成果

William Thomas Shearer的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是利用这些资源的众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. IMPAACT protocol that utilizes QHPV - P1047 is a closed protocol that is investigating the safety and immunogenicity of QHPV in HIV-infected girls and boys, age 7 to 12 years of age. This study was a placebo-controlled trial that compared a recommended three dose schedule of QHPV in one study arm (Arm A) with an arm that received placebo (Arm B). At 96 weeks after study entry the QHPV recipients (Arm A) received a fourth dose of QHPV and were subsequently evaluated for evidence of an anamnestic antibody response. Also at 96 weeks the previous placebo recipients (Arm B) began the same three dose schedule of QHPV that was administered in Arm A. Thus, two different cohorts are currently available for future evaluation. In summary, we seek to determine the long-term durability and kinetics of the vaccine-induced HPV-type-specific antibody and CMI responses in HIV-infected children that were, and are being, immunized in P1047. These subjects are a unique cohort that will allow us to approach this specific clinical issue.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PACTG P1026S (VERSION 20), PHARMACOKINETIC PROPERTIES OF ANTIRETROVIRAL DRUG
  • 批准号:
    8356662
  • 项目类别:
  • 资助金额:
    $4.13万
  • 财政年份:
    2010
  • 负责人:
    William Thomas Shearer
  • 依托单位:
A5240 (VERSION 10) A PHASE II STUDY TO EVALUATE THE IMMUNOGENICITY AND SAFETY
  • 批准号:
    8356728
  • 项目类别:
  • 资助金额:
    $2.64万
  • 财政年份:
    2010
  • 负责人:
    William Thomas Shearer
  • 依托单位:
IMPAACT 1077HS (VS 10) HAART STANDARD VERSION OF THE PROMISE STUDY
  • 批准号:
    8356740
  • 项目类别:
  • 资助金额:
    $0.79万
  • 财政年份:
    2010
  • 负责人:
    William Thomas Shearer
  • 依托单位:
Baylor College of Medicine Clinical Trial Unit
  • 批准号:
    8138733
  • 项目类别:
  • 资助金额:
    $15.35万
  • 财政年份:
    2010
  • 负责人:
    William Thomas Shearer
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
  • 批准号:
    82505677
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.00万元
  • 批准年份:
    2025
  • 负责人:
    吕雨霏
  • 依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
  • 批准号:
    82574874
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2025
  • 负责人:
    刘天华
  • 依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位: